Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/18/15 → 11/18/18 |
Funding
- PRA Health Sciences (GS-US-367-1171 // GS-US-367-1171)
- Gilead Sciences, Inc (GS-US-367-1171 // GS-US-367-1171)
Prot # GS-US-367-1171:Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Safety and Efficacy of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination for 12 Weeks in Direct-Acting Antiviral-Experienced Subjects with Chronic HCV Infectio
- Flamm, Steven L (PD/PI)
Project: Research project